Distinguished Professor of Neurology, University of California Irvine
Howard J. Federoff, MD, PhD
Dr. Howard Federoff MD, Ph.D., FAAAS earned his MS, PhD in Biochemistry and MD degrees from Albert Einstein College of Medicine of Yeshiva University. He completed his internship, residency, and fellowships at Massachusetts General Hospital/Harvard Medical School. He founded the Division of Molecular Medicine and Gene Therapy in the Department of Neurology, and later the Center for Aging and Developmental Biology at the University of Rochester School of Medicine and Dentistry. In 2003 he founded with U54 funding from NINDS the Parkinson’s Disease Gene Therapy Group which led the effort to bring AAV-GDNF into early clinical development in the NIH Clinical Center. In 2007 he assumed the role of EVP for Health Sciences/Executive Dean at Georgetown University. There, he was Professor of Neurology and Neuroscience and his research interests included gene therapy and neurodegenerative diseases such as Parkinson’s, Alzheimer’s, and prion diseases. He is a nationally renowned clinical and research leader and groundbreaking investigator for neurological disorders. He is currently Distinguished Professor of Neurology at University of California Irvine (UCI), College of Medicine where he was previously Dean of Medicine, CEO of the UCI Health System and Vice Chancellor for Health Affairs. At UCI, Dr. Federoff led alignment between and clinical expansion and of academic and research missions. He oversaw the creation of the Susan Samueli Institute for Integrative Health, the Medical Innovation Institute, and the Center for Precision and Population Health, and he co-founded the Institute for Future Health. He holds a number of medical patents with other patents pending. His research has received support from the National Science Foundation, the National Institutes of Health, and the U.S. Department of Defense. He has published more than 250 peer reviewed and invited articles and serves on the editorial boards of five journals including Gene Therapy, Experimental Neurology, and Brain and Mind. Dr. Federoff chaired the NIH RAC (Recombinant DNA Advisory Committee) and the GTRP (Gene Therapy Resource Program) for NHLBI, was President for ASNTR (American Society for Neural Therapy and Repair) and President of ASENT (American Society for Experimental Neurotherapeutics), and chair of the AAHC (Association of Academic Health Centers) Board. He currently serves as Director for Perthera, Inc. and chairs the Board of Directors for Souviens, Inc. He has recently taken the additional role as CEO for San Diego based Aspen Neuroscience, Inc., a regenerative medicine company. He co-founded several biotechnology companies. He is an elected Fellow of the American Association for the Advancement of Science and the National Academy of Inventors.